Page last updated: 2024-08-24

1-hexacosanol and Alloxan Diabetes

1-hexacosanol has been researched along with Alloxan Diabetes in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Adachi, K; Hanada, T; Kinoshita, Y; Kono, T; Nanba, E; Saito, M; Satoh, I; Satoh, K; Shinbori, C; Suzuki, H; Yamada, M2
Anastasios, S; Kinoshita, Y; Kono, T; Saito, M; Satoh, I; Satoh, K; ShinBori, C; Suzuki, H; Yamada, M1
Hanada, T; Kanzaki, S; Saito, M1
Hisadome, Y; Kazuyama, E; Kinoshita, Y; Narimatsu, N; Okada, S; Saito, M; Satoh, I; Satoh, K; Suzuki, H; Yamada, M1

Other Studies

5 other study(ies) available for 1-hexacosanol and Alloxan Diabetes

ArticleYear
N-hexacosanol reverses diabetic induced muscarinic hypercontractility of ileum in the rat.
    European journal of pharmacology, 2006, Sep-18, Volume: 545, Issue:2-3

    Topics: Animals; Calcium; Diabetes Mellitus, Experimental; Diabetic Neuropathies; Fatty Alcohols; Ileum; Male; Muscle Contraction; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Streptozocin

2006
Preventive effects of cyclohexenonic long-chain fatty alcohol on diabetic cystopathy in the rat.
    Canadian journal of physiology and pharmacology, 2006, Volume: 84, Issue:2

    Topics: Animals; Cyclohexanes; Cyclohexenes; Diabetes Mellitus, Experimental; Fatty Alcohols; Male; Rats; Rats, Sprague-Dawley; Urinary Bladder; Urinary Bladder Diseases; Urination

2006
Treatment with cyclohexenonic long-chain fatty alcohol reverses diabetes-induced tracheal dysfunction in the rat.
    Pharmacology, 2006, Volume: 78, Issue:2

    Topics: Animals; Body Weight; Carbachol; Diabetes Mellitus, Experimental; Fatty Alcohols; Female; Immunohistochemistry; Muscle Contraction; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M2; Receptor, Muscarinic M3; Reverse Transcriptase Polymerase Chain Reaction; Trachea

2006
Cyclohexenonic long-chain fatty alcohol has therapeutic effects on diabetes-induced angiopathy in the rat aorta.
    European journal of pharmacology, 2007, Jul-12, Volume: 567, Issue:1-2

    Topics: Animals; Aorta, Thoracic; Diabetes Mellitus, Experimental; Diabetic Angiopathies; Fatty Alcohols; In Vitro Techniques; Male; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Sprague-Dawley; Receptor, Muscarinic M3; RNA, Messenger

2007
N-hexacosanol prevents diabetes-induced rat ileal dysfunction without qualitative alteration of the muscarinic receptor system.
    Biomedical research (Tokyo, Japan), 2007, Volume: 28, Issue:5

    Topics: Animals; Diabetes Mellitus, Experimental; Fatty Alcohols; Gastrointestinal Motility; Ileal Diseases; Ileum; Male; Muscarinic Antagonists; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic

2007